Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer
IAF Muniz, M Araujo, J Bouassaly, F Farshadi… - International Journal of …, 2024 - mdpi.com
The use of conventional chemotherapy in conjunction with targeted and immunotherapy
drugs has emerged as an option to limit the severity of side effects in patients diagnosed …
drugs has emerged as an option to limit the severity of side effects in patients diagnosed …
[HTML][HTML] Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives
Y Liu, Y Deng, C Yang, H Naranmandura - Bioengineering, 2024 - mdpi.com
Cyclin-dependent kinases (CDKs) are generally involved in the progression of cell cycle and
cell division in normal cells, while abnormal activations of CDKs are deemed to be a driving …
cell division in normal cells, while abnormal activations of CDKs are deemed to be a driving …
The role of upfront neck dissection in definitive radiotherapy for locally advanced hypopharyngeal squamous cell carcinoma: A single‐center retrospective analysis
A Katano, H Yamashita, Y Saito, K Kobayashi - Head & Neck, 2024 - Wiley Online Library
Abstract Background Hypopharyngeal cancer, constituting 3%–5% of head and neck
cancers, predominantly presents as squamous cell carcinoma, with a 5‐year overall survival …
cancers, predominantly presents as squamous cell carcinoma, with a 5‐year overall survival …
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry …
FP Worden, E Pisick, M Rothe, PK Mangat… - JCO Precision …, 2024 - ascopubs.org
PURPOSE Targeted Agent and Profiling Utilization Registry is a phase II basket trial
evaluating the antitumor activity of commercially available targeted agents in patients with …
evaluating the antitumor activity of commercially available targeted agents in patients with …
Investigating radiation therapy treatments with cell cycle and DNA repair inhibitors in triple-negative breast cancer
YC Tsai - 2024 - escholarship.mcgill.ca
Triple-negative breast cancers (TNBCs) are the most aggressive and the deadliest of all
breast cancer molecular subtypes. Patients with TNBCs have limited treatment options and …
breast cancer molecular subtypes. Patients with TNBCs have limited treatment options and …